Advertisement

Topics

Permanent J Code Issued for Avedro’s Photrexa® Drug Formulations

08:00 EST 20 Nov 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
J Code 2787, Effective January 1, 2019, Expected to Streamline Reimbursement and Expand Patient Access Avedro, Inc., a leading commercial-stage ophthalmic medical technology company and a global leader in co...

Other Sources for this Article

Avedro Contact:
David Iannetta
Avedro, Inc.
(781) 768-3400
info@avedro.com

Media Contact:
Michele Gray
Gray Communications, llc.
(917) 449-9250
michele_gray@me.com

NEXT ARTICLE

More From BioPortfolio on "Permanent J Code Issued for Avedro’s Photrexa® Drug Formulations"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...